These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 8212164)
1. Reversal of ongoing heart, kidney, and pancreas allograft rejection and suppression of accelerated heart allograft rejection in the rat by rapamycin. Chen H; Wu J; Xu D; Luo H; Daloze PM Transplantation; 1993 Sep; 56(3):661-6. PubMed ID: 8212164 [TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of mycophenolate mofetil and sirolimus in prevention of acute heart, pancreas, and kidney allograft rejection and in reversal of ongoing heart allograft rejection in the rat. Vu MD; Qi S; Xu D; Wu J; Peng J; Daloze P; Sehgal S; Leduc B; Chen H Transplantation; 1998 Dec; 66(12):1575-80. PubMed ID: 9884242 [TBL] [Abstract][Full Text] [Related]
3. The mechanism of unresponsiveness to allografts induced by rapamycin and rapamycin/cyclosporine treatment in rats. Ferraresso M; Ghobrial R; Stepkowski SM; Kahan BD Transplantation; 1993 Apr; 55(4):888-94. PubMed ID: 8475565 [TBL] [Abstract][Full Text] [Related]
4. Rapamycin, a potent immunosuppressive drug for vascularized heart, kidney, and small bowel transplantation in the rat. Stepkowski SM; Chen H; Daloze P; Kahan BD Transplantation; 1991 Jan; 51(1):22-6. PubMed ID: 1987691 [TBL] [Abstract][Full Text] [Related]
5. Evidence that rapamycin rescue therapy delays rejection of major (MHC) plus minor (non-MHC) histoincompatible heart allografts in rats. Wang ME; Stepkowski SM; Ferraresso M; Kahan BD Transplantation; 1992 Oct; 54(4):704-9. PubMed ID: 1412762 [TBL] [Abstract][Full Text] [Related]
6. Rapamycin reverses acute heart, kidney, and pancreas allograft rejection and prevents accelerated heart allograft rejection in the rat. Chen H; Wu J; Xu D; Luo H; Daloze P Transplant Proc; 1993 Feb; 25(1 Pt 1):719-20. PubMed ID: 8438454 [No Abstract] [Full Text] [Related]
7. Rapamycin inhibits production of cytotoxic but not noncytotoxic antibodies and preferentially activates T helper 2 cells that mediate long-term survival of heart allografts in rats. Ferraresso M; Tian L; Ghobrial R; Stepkowski SM; Kahan BD J Immunol; 1994 Oct; 153(7):3307-18. PubMed ID: 8089500 [TBL] [Abstract][Full Text] [Related]
8. 15AU81, a prostacyclin analog, enhances donor-specific hepatocytes to prolong the survival of rat heart but not small bowel allografts. Boyle MJ; Dumble LJ Cell Transplant; 1999; 8(5):543-8. PubMed ID: 10580348 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of host-versus-graft and graft-versus-host responses after small bowel transplantation in rats by rapamycin. Stepkowski SM; Chen HF; Wang ME; Daloze P; Kahan BD Transplantation; 1992 Feb; 53(2):258-64. PubMed ID: 1738917 [TBL] [Abstract][Full Text] [Related]
10. Reversal of ongoing rejection of allografts by rapamycin. Chen HF; Wu JP; Luo HY; Daloze PM Transplant Proc; 1991 Aug; 23(4):2241-2. PubMed ID: 1871859 [No Abstract] [Full Text] [Related]
11. Synergistic interaction of 3 M KCl-extracted donor antigens (e-HAg) with cyclosporine or cyclosporine/sirolimus for prolongation of rat heart allograft survival. Hamashima T; Stepkowski SM; Chou TC; Kahan BD Transpl Immunol; 1995 Dec; 3(4):335-41. PubMed ID: 8665153 [TBL] [Abstract][Full Text] [Related]
12. Synergistic mechanisms by which sirolimus and cyclosporin inhibit rat heart and kidney allograft rejection. Stepkowski SM; Tian L; Napoli KL; Ghobrial R; Wang ME; Chou TC; Kahan BD Clin Exp Immunol; 1997 Apr; 108(1):63-8. PubMed ID: 9097913 [TBL] [Abstract][Full Text] [Related]
13. Effect of a short course of rapamycin, cyclosporin A, and donor-specific transfusion on rat cardiac allograft survival. Davies CB; Madden RL; Alexander JW; Cofer BR; Fisher RA; Anderson P Transplantation; 1993 May; 55(5):1107-12. PubMed ID: 8497890 [TBL] [Abstract][Full Text] [Related]
14. Long-term in vivo effects of rapamycin on humoral and cellular immune responses in the rat. Chen H; Luo H; Daloze P; Xu D; Shan X; St-Louis G; Wu J Immunobiology; 1993 Jul; 188(3):303-15. PubMed ID: 8225391 [TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive effects of the cyclosporin derivative SDZ IMM 125 on kidney allograft in the dog and small bowel and pancreas allografts in the rat. Chen H; Qi S; Xu D; Bergeron E; Wu J; Beauregard-Zollinger L; Tan A; Daloze P Clin Immunol Immunopathol; 1996 Jul; 80(1):76-81. PubMed ID: 8674242 [TBL] [Abstract][Full Text] [Related]
16. Intrasplenic liver parenchymal cells in conjunction with low-dose rapamycin and cyclosporine induce a unique and specific prolongation of rat cardiac and small bowel allograft survival. Boyle MJ; Baghdassarian V; Stepkowski SM; Dumble LJ; Kahan BD Cell Transplant; 1998; 7(3):247-56. PubMed ID: 9647434 [TBL] [Abstract][Full Text] [Related]
17. Combination therapy of mycophenolate mofetil and rapamycin in prevention of chronic renal allograft rejection in the rat. Jolicoeur EM; Qi S; Xu D; Dumont L; Daloze P; Chen H Transplantation; 2003 Jan; 75(1):54-9. PubMed ID: 12544871 [TBL] [Abstract][Full Text] [Related]
18. Protection against allograft rejection with intercellular adhesion molecule-1 antisense oligodeoxynucleotides. Stepkowski SM; Wang ME; Condon TP; Cheng-Flournoy S; Stecker K; Graham M; Qu X; Tian L; Chen W; Kahan BD; Bennett CF Transplantation; 1998 Sep; 66(6):699-707. PubMed ID: 9771832 [TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus. Wang ME; Tejpal N; Qu X; Yu J; Okamoto M; Stepkowski SM; Kahan BD Transplantation; 1998 Apr; 65(7):899-905. PubMed ID: 9565092 [TBL] [Abstract][Full Text] [Related]
20. Effects of rapamycin in experimental organ allografting. Ochiai T; Gunji Y; Nagata M; Komori A; Asano T; Isono K Transplantation; 1993 Jul; 56(1):15-9. PubMed ID: 8333037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]